A team of doctors and scientists have found "clear evidence" of a cause of neurodegeneration in people with Alzheimer’s disease."Changes in the orchestration of brain oxygenation dynamics and neuronal ...

A research team has discovered that the two key pathological hallmarks of Alzheimer's -- tau protein and beta-amyloid -- affect brain circuits in distinct yet synergistic ways, particularly those ...

Scientists have discovered a potential new drug that could help people with Alzheimer’s disease by improving memory and ...

A new platform for studying neuroinflammatory diseases, utilizing advanced 3D bioprinting technology has been developed.

Nearly every disease has an inflammatory component, but blood tests can't pinpoint inflammation in specific organs or tissues in the human body.

For years, scientists have focused on amyloid beta buildup as the main culprit in Alzheimer’s disease, but a new study suggests the real problem might lie in a stalled protein-cutting process in the ...

First patients with memory problems join ‘revolutionary’ trial by Oxford and Cambridge universities which could lead to ‘Holy ...

A research team from the Institut de Neurociències of the Universitat Autònoma de Barcelona (INc-UAB) has discovered that the ...

University of Oklahoma's Dr. Sreemathi Logan leads a study on dementia, backed by a $2.2 million grant, focusing on aging, ...

A pathway once considered fundamental in Alzheimer’s disease is being studied intensely again, and may soon result in safer, ...

The type of bacteria in your mouth may affect your memory, attention and thinking abilities, a study suggests.

There are over 120 drugs being tested in clinical trials, and two, lecanemab and donanemab, have made headline news as the UK’s first-ever approved drugs for treating early-stage Alzheimer’s disease .